Spinal Cord Stimulator Glassed Feedthrough Improvement Using DMADV Methodology

Abstract

Chronic pain is an illness that affects more than 1.5 billion humans worldwide and can affect daily activities leading up to disability and despair. The goal of treating chronic pain is to reduce pain and improve function so that a person can resume day-to-day activities. The neurological device supplied by a private medical device company is a spinal cord stimulator therapy which masks pain signals before they reach the brain and produces relief to the patient. This investigation will analyze the manufacturing operation optimization using a Six Sigma framework to investigate ways to generate more revenue from a commercially released medical device. Key Terms ⎯ Chronic Pain, DMADV, Food and Drug Administration, Neurological, Spinal Cord Stimulator.